India Single-Use Bioreactors Market (2026-2031)
The India Single-Use Bioreactors Market was valued at $59.9 Million in 2026 and projected to reach to $106.6 Million by 2031, representing a compound annual growth rate of 12.2%. India's single-use bioreactors market is poised for sustained growth as the country strengthens its position in global biopharmaceutical manufacturing.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Single-Use Bioreactors Market Trends and Insights
- India is emerging as a critical hub for biopharmaceutical manufacturing, driven by increasing investments in cell and gene therapy production, vaccine development, and contract manufacturing organizations (CMOs) adopting single-use technologies.
- The market growth in India reflects the country's strategic position in global biologics supply chains and rising demand for flexible, cost-effective manufacturing solutions. India's adoption of single-use bioreactors is accelerating due to regulatory support, skilled workforce availability, and lower operational costs compared to traditional stainless-steel systems.
- India's pharmaceutical and biotechnology sectors are increasingly transitioning to single-use platforms to reduce capital expenditure, minimize contamination risks, and accelerate time-to-market for biologics.
- Between 2026 and 2031, India is expected to capture significant market share within the Asia Pacific region, supported by government initiatives promoting biotech innovation and foreign direct investment in manufacturing infrastructure..
Key Market Statistics
- CAGR (2026-2031) 12.2% CAGR
- Market Size, 2026 ~USD 59.9 Million
- Forecast, 2031 ~USD 106.6 Million
- Country India
India Single-Use Bioreactors Market Overview
Rapid Market Growth :
India's single-use bioreactors market is expanding at a CAGR of 12.2%, growing from USD 59.9 million in 2026 to USD 106.6 million by 2031, outpacing the global average of 12%.
CMO & Contract Manufacturing Boom :
Indian contract manufacturing organizations are increasingly adopting single-use bioreactor technologies to reduce capital expenditure, improve operational flexibility, and accelerate time-to-market for biopharmaceutical clients.
Cell & Gene Therapy Hub :
India is positioning itself as a critical manufacturing hub for cell and gene therapies, with significant investments in advanced bioreactor infrastructure to support clinical and commercial-scale production.
Vaccine Development Acceleration :
India's robust vaccine manufacturing ecosystem is driving demand for single-use bioreactors, particularly for mRNA and viral vector-based vaccine production platforms.
India Single-Use Bioreactors Market Dynamics
- Government initiatives promoting biotech investments, coupled with rising demand from domestic and international pharmaceutical companies, are creating favorable conditions for market expansion.
- The shift toward single-use technologies is driven by cost efficiency, reduced contamination risks, and faster production cycles. Key growth drivers include increasing prevalence of chronic diseases, expanding vaccine development programs, and the emergence of India as a preferred destination for contract manufacturing.
- With major pharmaceutical companies establishing or expanding manufacturing facilities, the adoption of single-use bioreactors is expected to accelerate significantly through 2031, positioning India as a competitive player in the global bioreactor market..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- India's single-use bioreactors market is valued at USD 59.9 million in 2026 and will grow to USD 106.6 million by 2031, representing a 12.2% CAGR.
- India is positioning itself as a global biopharmaceutical manufacturing hub, with CMOs and domestic biotech firms increasingly adopting single-use technologies.
- Cost advantages and regulatory support in India are driving rapid adoption of single-use bioreactors over traditional stainless-steel systems.
- India's expanding cell and gene therapy and vaccine production capabilities are key growth drivers for the single-use bioreactors market through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
India Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Bioreactor Equipment Manufacturers : Need India market data to assess demand for single-use bioreactor systems, identify growth segments (vaccines, cell therapy), and develop localized product strategies for Indian CMOs and pharmaceutical companies.
- Contract Manufacturing Organizations (CMOs) : Require market insights to benchmark technology adoption rates, understand competitive positioning, and make informed capital investment decisions for single-use bioreactor infrastructure expansion.
- Biopharmaceutical Companies : Need India-specific market intelligence to evaluate manufacturing partnerships, assess CMO capabilities in single-use technology, and plan production outsourcing strategies for cost optimization.
- Private Equity & Investment Firms : Seek detailed market analysis to identify investment opportunities in Indian biotech manufacturing, CMO consolidation, and bioreactor technology providers with high growth potential.
- Government & Policy Makers : Require market data to evaluate biotech sector growth, assess manufacturing infrastructure needs, and develop policies supporting India's position as a global biopharmaceutical manufacturing hub.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for India (USD 59.9M in 2026) and verified 5-year forecast (USD 106.6M by 2031) to support investment decisions and business planning in the Indian bioreactor sector.
- India-Specific Competitive Landscape : Identify key players, CMOs, and biopharmaceutical manufacturers adopting single-use technologies in India, enabling targeted partnership and market entry strategies.
- Regulatory & Infrastructure Insights : Understand India-specific regulatory frameworks, manufacturing standards, and infrastructure developments shaping single-use bioreactor adoption across domestic and contract manufacturing segments.
- Segment & Application Analysis : Access detailed breakdown of India's market by application (vaccines, cell therapy, gene therapy, CMO services) to identify high-growth opportunities and customer segments.
- Strategic Growth Opportunities : Leverage India-focused insights on emerging trends, government initiatives, and investment patterns to develop localized go-to-market strategies and capitalize on the 12.2% CAGR expansion.
Frequently asked questions
What is the current market size of single-use bioreactors in India?
India's single-use bioreactors market was valued at USD 59.9 million in 2026 and is projected to reach USD 106.6 million by 2031.
What is the expected growth rate for India's single-use bioreactors market?
India's single-use bioreactors market is expected to grow at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2031.
Why is India adopting single-use bioreactors rapidly?
India is adopting single-use bioreactors due to lower operational costs, reduced capital expenditure, minimized contamination risks, faster time-to-market, regulatory support, and a skilled workforce in the biopharmaceutical sector.
Which sectors in India are driving single-use bioreactors demand?
India's demand for single-use bioreactors is driven by contract manufacturing organizations (CMOs), vaccine manufacturers, cell and gene therapy developers, and domestic biopharmaceutical companies.
How does India's market compare to the global single-use bioreactors market?
India's single-use bioreactors market is growing at 12.2% CAGR, aligned with the global market growth rate of 12%, positioning India as a key regional contributor within Asia Pacific.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
